Latest filing published 03 Apr 2015 for SALIX PHARMACEUTICALS LTD, €12.0M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Alonzo Thomas D appears in our data through filings on Salix Pharmaceuticals Ltd shares, published by SEC (Form 4). The record holds 60 filings, for trades running from 8 May 2006 to 1 April 2015.
On the open market, the record shows 7 purchases worth €109k and 21 sales worth €2.7M. On balance, insiders were net sellers of €2.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 18 share grants and 6 option exercises.
The median purchase comes to €10k.
The latest filing, published on 3 April 2015, reports a transaction of €12.0M in Salix Pharmaceuticals Ltd. The last purchase on record was published on 11 August 2011, which is 5,553 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 58 declarations